Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: Potential application to choroidal neovascularization

被引:36
作者
Bargagna-Mohan, Paola
Ravindranath, Padma Priya
Mohan, Royce
机构
[1] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
D O I
10.1167/iovs.05-1452
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To characterize the angiogenic and inflammatory responses of human choroidal endothelial cells (HCECs) to stimulators and inhibitors of the ubiquitin proteasome pathway (UPP). METHODS. The regulation of the UPP by the inhibitor withaferin A and its congener, withanolide D, two natural products derived from the medicinal plant Withania somnifera was assessed in the three-dimensional endothelial cell sprouting assay (3D-ECSA), by using HCEC- and human umbilical vein endothelial cell (HUVEC)-derived spheroids embedded in a collagen I matrix. Western blot analysis was used to investigate the effect of withanolides on I kappa B-alpha, polyubiquitination, and heme oxygenase (HO)-1 regulation in HCEC and HUVEC cultures. RESULTS. HCECs, like HUVECs, responded to fibroblast growth factor-2, vascular endothelial growth factor, and tumor necrosis factor (TNF)-alpha stimulation and sprouted vessel-like structures in collagen I matrix. However, HCECs were slower to generate these sprouting vessels, when compared with HUVECs. The extent of inhibition of endothelial cell sprouting in 3D matrix, the blockade of TNF-alpha-induced I kappa B-alpha degradation, levels of global polyubiquitinated proteins, and induced production of HO-1 in response to treatment by the withanolides in cultured endothelial cells was similarly regulated between HCECs and HUVECs. CONCLUSIONS. HCECs share with HUVECs a similar response to UPP inhibitors, suggesting that this well-conserved pathway that regulates angioinflammatory mechanisms could be exploited for drug-targeting in the development of novel agents for CNV treatment.
引用
收藏
页码:4138 / 4145
页数:8
相关论文
共 48 条
[1]   An animal model of age-related macular degeneration in senescent Ccl-2-or Ccr-2-deficient mice [J].
Ambati, J ;
Anand, A ;
Fernandez, S ;
Sakurai, E ;
Lynn, BC ;
Kuziel, WA ;
Rollins, BJ ;
Ambati, BK .
NATURE MEDICINE, 2003, 9 (11) :1390-1397
[2]   Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies [J].
Ambati, J ;
Ambati, BK ;
Yoo, SH ;
Ianchulev, S ;
Adamis, AP .
SURVEY OF OPHTHALMOLOGY, 2003, 48 (03) :257-293
[3]   NF-κB activation in cancer:: a challenge for ubiquitination- and proteasome-based therapeutic approach [J].
Amit, S ;
Ben-Neriah, Y .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :15-28
[4]   Evidence for an inflammatory process in age-related macular degeneration gains new support [J].
Bok, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (20) :7053-7054
[5]   Isolation, culture, and characterisation of human macular inner choroidal microvascular endothelial cells [J].
Browning, AC ;
Gray, T ;
Amoaku, WM .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (10) :1343-1347
[6]  
Budhiraja RD, 2000, J SCI IND RES INDIA, V59, P904
[7]   Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury [J].
Chen, J ;
Regan, RF .
CURRENT NEUROVASCULAR RESEARCH, 2005, 2 (03) :189-196
[8]   Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[9]   Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting [J].
Ciechanover, A .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (09) :1178-1190
[10]   Monocyte activation in patients with age-related macular degeneration - A biomarker of risk for choroidal neovascularization? [J].
Cousins, SW ;
Espinosa-Heidmann, DG ;
Csaky, KG .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (07) :1013-1018